{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.572","meta":{"versionId":"5","lastUpdated":"2023-04-03T13:49:29.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.572","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.572"}],"version":"20190302","name":"EstrogenAndProgesteroneReceptorNegativeBreastCancer","title":"Estrogen and Progesterone Receptor Negative Breast Cancer","status":"active","experimental":false,"date":"2019-03-02T01:00:10-05:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"3316F","display":"Estrogen receptor (ER) and progesterone receptor (PR) negative breast cancer (ONC)"}]}]},"expansion":{"identifier":"urn:uuid:7c09315c-ddfe-4ab0-b75a-04d9d0f9964c","timestamp":"2023-12-10T21:42:54-05:00","total":1,"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"3316F","display":"Estrogen receptor (ER) and progesterone receptor (PR) negative breast cancer (ONC)"}]}}